Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Headache Disorders Market Today And What Is Its Future Size?

Over the past few years, the market size of headache disorders has significantly expanded. The market, which is projected to rise from $4.64 billion in 2024 to $4.93 billion in 2025, touts a compound annual growth rate (CAGR) of 6.2%. The contemporary growth trends are linked to a lack of adequate treatment alternatives, increased cognizance, a surge in headache cases, advancement in healthcare systems, lifestyle changes, and increasing stress levels.

The market size for headache disorders is predicted to witness a notable surge in the coming years, reaching a value of “$6.83 billion in 2029” with a compound annual growth rate (CAGR) of 8.5%. This anticipated growth can be credited to the rise of digital health solutions, tailoring of medicine to individual patients, increased investment in research and development, an aging global populace, and more extensive research in the field of neuroinflammation. The expected trends for the forecast period include advancements in therapy technology, a shift towards personalized treatment, a growing emphasis on pre-emptive therapy strategies, an enlarging scope of new therapy procedures, and a heightened interest in non-pharmacological methods.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9452&type=smp

What Drivers Are Accelerating Expansion Of The Headache Disorders Market?

The growth of the headache disorders market is predicted to be fuelled by the rising frequency of migraines. A migraine is a form of headache marked by recurring spells of moderate to severe throbbing and pulsating pain on one side of the head. Headache disorders could lead to neurological issues resulting in debilitating throbbing pain, fatigue, and nausea, potentially triggering migraines. For example, in April 2022, a UK-based Peer-reviewed journal, the Journal of Headache and Pain, reported that an active headache disorder of some kind was found in 52.0% of the populations surveyed, with 44.4% prevalence in males and 57.8% in females. Migraine afflicted 14.0% of the population (8.6% in males and 17.0% in females), whereas tension-type headache (TTH) was observed in 26.0%, affecting 23.4% of males and 27.1% of females. Hence, the escalating frequency of migraines is stimulating the demand for the headache disorders market.

What Are The Main Segment Classifications In The Headache Disorders Market?

The headache disorders market covered in this report is segmented –

1) By Type: Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse Headache, Other Types

2) By Treatment: Medication, Heat Therapy, Diet Changes, Acupuncture, Oxygen Therapy

3) By Diagnosis: Complete Blood Count, Skull X-Rays, Sinus X-Rays, CT Scan, Magnetic Resonance Imaging (MRI)

4) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Migraine: Chronic Migraine, Episodic Migraine, Migraine With Aura, Migraine Without Aura

2) By Tension-Type Headache: Episodic Tension-Type Headache, Chronic Tension-Type Headache

3) By Cluster Headache: Chronic Cluster Headache, Episodic Cluster Headache

4) By Medication-Overuse Headache: Analgesic-Overuse Headache, Caffeine-Withdrawal Headache

5) By Other Types: Sinus Headache, Hormonal Headache, Thunderclap Headache, Other Primary And Secondary Headaches

How Are Industry Trends Steering The Expansion Of The Headache Disorders Market?

Prominent businesses within the headache disorder market are directing their efforts towards the creation of inventive products, like migraine tablets, with the aim to expand available treatment alternatives and improve patient results. Migraine tablets offer relief and prevention against migraines by specifically targeting pathways involved in symptoms such as inflammation and pain. An example of these efforts is Akums Drugs & Pharmaceuticals, a pharmaceutical manufacturer based in India, launching the Lasmiditan Tablet in January 2024. This product is a generic formulation of Eli Lilly’s REYVOW and is targeted at the quick treatment of migraines. Lasmiditan, which has received approval from the Drug Controller General of India (DCGI) and the US Food and Drug Administration (USFDA), works by connecting to the 5-HT1F serotonin receptor to disrupt pain signals and diminish nerve inflammation. It is recommended that doses are between 50 mg and 100 mg, and should not exceed one dose in 24 hours.

Which Companies Are Contributing Significantly To The Headache Disorders Market Growth?

Major companies operating in the headache disorders market include Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Novartis AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd, Emcure Pharmaceuticals Limited, Endo International plc, WorldMeds LLC, AstraZeneca plc, Bausch & Lomb Incorporated, Nichi-Iko Pharmaceutical Co, Upsher-Smith Laboratories LLC, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH., Gilead Sciences Inc., Amgen Inc., Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Eisai Co. Ltd., Impax Laboratories LLC, Lannett Company Inc., Lupin Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/headache-disorders-global-market-report

Which Region Holds The Greatest Opportunity For Headache Disorders Market Expansion?

North America was the largest region in the headache disorders market in 2024. The regions covered in the headache disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9452&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model